Biosimilars Market Role in Reducing Healthcare Costs and …
Dec 9, 2024 · The global biosimilars market is witnessing remarkable growth, driven by factors such as cost efficiency, increased demand for accessible healthcare solutions, and the expiration of patents for branded biologic drugs. With a market that was valued at approximately USD 20.4 billion in 2021, the biosimilars market is expected to expand significantly, reaching more than USD 85 billion by the end ...
PharmiWeb.com: The Heart of Life Sciences on the Web
PharmiWeb.com - Global pharma news from the pharmaceutical industry, biotech, clinical research, life science & healthcare. Pharma Events Listings, Pharma Company Directory & pharma jobs.
Combination of Poolbeg and HOOKIPA Pharma Inc
5 days ago · The boards of directors (each a "Board") of HOOKIPA Pharma Inc. ("HOOKIPA") and Poolbeg Pharma plc ("Poolbeg") are pleased to announce that they have entered into non-binding discussions for an all-share acquisition by HOOKIPA of Poolbeg (the "Potential Combination") to create a strong clinical-stage biopharmaceutical company focused on developing and commercialising innovative medicines for ...
75% of Hospitals Face Medication Shortages - pharmiweb.com
Dec 3, 2024 · Germfree Laboratories, On Demand Pharmaceuticals (ODP), and North Mississippi Medical Center-Tupelo (NMMC) have teamed up to address the global drug shortage crisis with a groundbreaking point-of-care medicine production solution. The expanding partnership aims to bring agile production of essential medicines ...
Ottimo Pharma Emerges from Stealth with Backing from Medicxi …
Oct 28, 2024 · · David Epstein, formerly CEO of Seagen, joins as Chair & Chief Executive Officer · Mehdi Shahidi, previously SVP and Chief Medical Officer at Boehringer Ingelheim, joins as Head of Development & Chief Medical Officer · James Sabry, ex-Head of Pharma Partnering at Roche, joins the Board as Vice-Chair [28 October 2024]: [London, UK/ Boston, US]: Ottimo Pharma, a private biotech company ...
Newron and EA Pharma (a subsidiary of Eisai Co., Ltd.) announce …
Dec 13, 2024 · EQS-News: Newron Pharmaceuticals S.p.A. / Key word(s): AgreementNewron and EA Pharma (a subsidiary of Eisai Co., Ltd.) announce license agreement for evenamide in Japan and other Asian territories 13.12.2024 / 07:00 CET/CESTThe issuer is solely responsible for the content of this announcement.Newron and EA Pharma (a...
Global GLP-1 Receptor Agonist Market Set for Exceptional Growth ...
Oct 21, 2024 · The global GLP-1 receptor agonist market is poised for extraordinary expansion, driven by an increase in therapeutic applications and favorable market projections. Recent analysis indicates a promising trajectory, with expectations for the market to grow from USD 23,854.53 million in 2024 to an impressive USD 72,127.79 million by 2034.
Top 12 Clinical Research Organisations (CROs) in 2023
Feb 23, 2023 · The global clinical trials market was estimated to be worth $38.7 billion in 2021 and is expected to reach £52 billion by 2026. In this article, we look at the top 12 CROs in the world, highlighting the companies driving this considerable growth and accelerating research and development across the globe.. ICON. Recognised as the world’s largest and most comprehensive CRO powered by ...
Naobios and Sumagen successfully optimize HIV vaccine …
Oct 29, 2024 · Key milestone reached within expected initial timelines with successful set up of cell growth and production of HIV-1 vaccine candidate at bench scalePhase I/II trial to assess safety and efficacy expected to start after cGMP production end of 2025 Nantes, France October 29, 2024 – Naobios, a CDMO (Contract Developm...
Global Sialendoscopes Market Set for Significant Growth, …
Dec 2, 2024 · The global sialendoscopes market is poised for substantial growth, with a projected Compound Annual Growth Rate (CAGR) of 5.6% from 2022 to 2032, according to recent industry analysis. In 2022, the market achieved a revenue of USD 169.2 million, and it is expected to surpass USD 307.9 million by 2032, signaling strong demand for advanced diagnostic and therapeutic tools for salivary gland ...